Cargando…
Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance
Increasing evidence has shown that mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) have unique clinical implications for breast cancer subtyping and classification, as well as for breast cancer targeted therapy. It is particularly important to clarify the co...
Autores principales: | Kong, Xin, Wang, Qi, Li, Jie, Li, Ming, Deng, Fusheng, Li, Chuanying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012142/ https://www.ncbi.nlm.nih.gov/pubmed/35388661 http://dx.doi.org/10.4081/ejh.2022.3315 |
Ejemplares similares
-
Characterization of GATA3 and Mammaglobin in breast tumors from African American women
por: Ricks-Santi, Luisel J., et al.
Publicado: (2023) -
Cutaneous Adnexal Cylindroma of Breast: Epithelial Immunoreactivities for GATA-3, Mammaglobin, and E-Cadherin Do Not Equate to a Mammary Ductal Neoplasm
por: Halima, A., et al.
Publicado: (2018) -
Comparison of GATA-3, Mammaglobin and GCDFP-15 Expression in Primary, Metastatic and Triple Negative Breast Carcinomas: An Indian Scenario
por: Rao, Meenakshi, et al.
Publicado: (2023) -
GATA3 Predicts the Tumor Microenvironment Phenotypes and Molecular Subtypes for Bladder Carcinoma
por: Zhang, Qixin, et al.
Publicado: (2022) -
Role of GATA binding protein 4 (GATA4) in the regulation of tooth development via GNAI3
por: Guo, Shuyu, et al.
Publicado: (2017)